NYSE Content advisory: Pre-Market update + ICE launches NYSE Elite Tech 100 Index
NEW YORK, July 10, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market update + Trump sets 35% tariff on Canada
NEW YORK, July 11, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports
NEW YORK, July 9, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content advisory: Pre-Market update + Trump announces new tariffs on 14 countries
NEW YORK, July 8, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market update + S&P 500 trades within 1% of record
NEW YORK, June 25, 2025 /PRNewswire/ -- The New York Stock Exchange…
Rainbow Productions receives the Kings Award for Enterprise
Tuesday 6 May, 2025 Not for publication before 1 AM on the…
NYSE Content advisory: Pre-Market update + House votes on Trump’s megabill
NEW YORK, July 2, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content advisory: Pre-Market update + June Jobs Report in focus
NEW YORK, July 3, 2025 /PRNewswire/ -- The New York Stock Exchange…
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
July 02, 2025 06:00 ET Â | Source: Instil Bio US phase 1…
NYSE Content Advisory: Pre-Market update + NYSE led globally in total capital raised during first half of 2025
NEW YORK, July 1, 2025 /PRNewswire/ -- The New York Stock Exchange…